Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Part 1 Article 2: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
imported>GxPlexBot Import from GxPlex Excel |
||
| Line 5: | Line 5: | ||
Article 2 | Article 2 | ||
|RefLanguage=EN | |RefLanguage=EN | ||
| | |RefTags=TAG-00286-Ele-sch ++ TAG-00244-Def-ini | ||
| | |RefModule=4 | ||
| | |RefUnit=4.2.4 | ||
}} | }} | ||
| Line 15: | Line 15: | ||
|- | |- | ||
! colspan="2" class="gplx-infobox-header" | Reference Details | ! colspan="2" class="gplx-infobox-header" | Reference Details | ||
|- | |||
! Module | |||
| Module 4 — Unit 4.2.4 | |||
|- | |- | ||
! Scope | ! Scope | ||
| Line 32: | Line 35: | ||
| | | | ||
|- | |- | ||
! Tags | ! Tags | ||
| | | [[Glossary:TAG-00286-Ele-sch|Electronic signature]], [[Glossary:TAG-00244-Def-ini|Definition]] | ||
|- | |||
| | |||
|- | |- | ||
! Comment | ! Comment | ||
Revision as of 17:29, 15 July 2026
| Document information | |
|---|---|
| Reference | GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 |
| Validity area | GBR |
| Scope(s) | HM |
| Document name | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Version / Revision | 01-May-2004 |
| Status | Current |
| Document type | Legal act |
| Language(s) | EN |
| Description | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 4 — Unit 4.2.4 |
| Scope | HM |
| Document part | Part 1
Article 2 |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Electronic signature, Definition |
| Comment | Definition of electronic signature (eIDAS) |
Content
“electronic signature” means data in electronic form which are attached to or logically associated with other electronic data and which serve as a method of authentication;
